| Company/Division name | Boston Scientific |
| Parent company | Boston Scientific |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 440 |
| Year reshoring announced: | 2025 |
| Year reshoring implemented or to be implemented: | 2026 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 102 |
| City reshored to: | Maple Grove |
| State(s) reshored to: | MN |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment & Supplies |
| Product(s) reshored | medical devices |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Government Incentives, Impact on domestic economy |
| Government Incentive dollar amount: | 1,666,000 |
